Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes
Clinical trial NCT01285518 · COMPLETED
Trial details
- NCT number
- NCT01285518
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2011-07-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.